Bristol Myers Squibb Provides Update on Phase 3 ODYSSEY-HCM Trial
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq futures slide as Alphabet results intensify AI spending fears
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 60.57 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $60.57 | 52 Week High | $77.12 | |||
| Open | $60.57 | 52 Week Low | $49.03 | |||
| Day High | $60.57 | P/E | 39.33 | |||
| Day Low | $60.57 | EPS | $1.54 | |||
| Volume | 30,666 | |||||
